Skip to content

Pasadena Star News

67°F
Friday, April 17th 2026

e-Edition

Trending:

Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

55.31 +0.89 (+1.64%)
Streaming Delayed Price Updated: 3:22 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease
From Tempus AI, Inc.
Via Business Wire
News headline image
2 AI Healthcare Stocks to Buy Right Now ↗
The convergence of two already fantastic industries is creating an incredible opportunity. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Want $1 Million in Retirement? Invest $10,000 in These 2 AI Stocks and Hold for 10 Years. ↗
AI is rewriting drug discovery. Recursion Pharmaceuticals and Tempus AI might be the platforms that turn early investors into millionaires. 
Via The Motley Fool
Topics Artificial Intelligence
Tempus AI Inc (NASDAQ:TEM) Reports Strong Q4 Revenue Beat and First Positive Adjusted EBITDA ↗
Via Chartmill
Topics Artificial Intelligence
Why Is Tempus AI Stock Surging 11% Premarket Today? ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine
From Tempus AI, Inc.
Via Business Wire
MarketBeat Week in Review – 02/23 - 02/27 ↗
Sometimes the best offense is a good defense. That’s what investors seem to be feeling. Technology stocks continue to be under pressure, and that money is flowing into traditionally defensive assets... 
Via MarketBeat
News headline image
After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus AI Sold Off After a Beat—But the Rebound Case Is Building ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
Tempus Reports Fourth Quarter and Full Year 2025 Results
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24
From Tempus AI, Inc.
Via Business Wire
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
The widely followed growth investor keeps making moves. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Ambry’s Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes
From Ambry Genetics
Via Business Wire
News headline image
Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield
From Ambry Genetics
Via Business Wire
News headline image
Here Are Congresswoman Nancy Pelosi's Initial Stock Moves in 2026: They Include Nvidia, Alphabet, and Amazon Stocks, and Others ↗
The main theme in Nancy Pelosi's stock investments remains "betting big on AI." 
Via The Motley Fool
Topics Bonds
News headline image
Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers
From Tempus AI, Inc.
Via Business Wire
News headline image
Pelosi’s Bullish 2026 Buy List: AI, Power & Dividends ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
Ark Invest is beating the market again in 2026, and the iconic growth investor wants to keep it that way. 
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
Tempus Announces the Launch of Paige Predict
From Tempus AI, Inc.
Via Business Wire
News headline image
Why Tempus AI Stock Rose Today ↗
The data provider's artificial intelligence-driven solutions are accelerating drug discovery. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology
From Tempus
Via Business Wire
News headline image
Northwestern Medicine Selects Tempus to Expand Genomic Testing
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus AI Stock Soars After Posting Triple-Digit Diagnostics Growth ↗
Tempus AI (NASDAQ: TEM) stock rose after releasing preliminary Q4 and 2025 results, with revenue of $1.27B in 2025 and $367M in Q4. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results
From Tempus AI, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.